Does the media favor HSIC or COO?

In the previous week, Cooper Companies had 14 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for Cooper Companies and 8 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.64 beat Cooper Companies' score of 0.51 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cooper Companies 3 Very Positive mention(s) 6 Positive mention(s) 7 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HSIC or IDXX?

In the previous week, Henry Schein had 1 more articles in the media than IDEXX Laboratories. MarketBeat recorded 8 mentions for Henry Schein and 7 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.55 beat Henry Schein's score of 0.64 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IDEXX Laboratories 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor HSIC or MMSI?

In the previous week, Henry Schein had 4 more articles in the media than Merit Medical Systems. MarketBeat recorded 8 mentions for Henry Schein and 4 mentions for Merit Medical Systems. Henry Schein's average media sentiment score of 0.64 beat Merit Medical Systems' score of 0.63 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, HSIC or PODD?

Henry Schein has higher revenue and earnings than Insulet. Henry Schein is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.18B 0.72 $398M $3.43 24.79 Insulet $2.71B 3.54 $247.10M $5.35 25.82

Is HSIC or PODD more profitable?

Insulet has a net margin of 12.29% compared to Henry Schein's net margin of 2.96%. Insulet's return on equity of 29.29% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Henry Schein 2.96% 15.97% 5.56% Insulet 12.29% 29.29% 13.31%

Does the media prefer HSIC or PODD?

In the previous week, Henry Schein and Henry Schein both had 8 articles in the media. Insulet's average media sentiment score of 0.70 beat Henry Schein's score of 0.64 indicating that Insulet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Insulet 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or HSIC?

In the previous week, Henry Schein had 4 more articles in the media than AMN Healthcare Services. MarketBeat recorded 8 mentions for Henry Schein and 4 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 0.64 beat AMN Healthcare Services' score of 0.46 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Henry Schein (HSIC) Competitors

$85.03 +0.80 (+0.95%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$85.02 -0.01 (-0.01%)

As of 10/13/2026 07:30 PM Eastern

Compare

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

Should you buy Henry Schein stock or one of its competitors? Henry Schein's main competitors and comparable companies include Cooper Companies (COO), IDEXX Laboratories (IDXX), Merit Medical Systems (MMSI), Insulet (PODD), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Henry Schein compare to Cooper Companies?

Henry Schein (NASDAQ:HSIC) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Cooper Companies had 14 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for Cooper Companies and 8 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.64 beat Cooper Companies' score of 0.51 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	3 Very Positive mention(s)	6 Positive mention(s)	7 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Henry Schein currently has a consensus price target of $92.93, indicating a potential upside of 9.29%. Cooper Companies has a consensus price target of $68.60, indicating a potential upside of 25.66%. Given Cooper Companies' higher probable upside, analysts clearly believe Cooper Companies is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53
Cooper Companies	2 Sell rating(s)	13 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.11

Henry Schein has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.43	24.79
Cooper Companies	$4.09B	2.54	$374.90M	$2.93	18.63

Henry Schein has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Cooper Companies has a net margin of 13.46% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Cooper Companies	13.46%	10.90%	7.24%

Summary

Henry Schein beats Cooper Companies on 10 of the 16 factors compared between the two stocks.

How does Henry Schein compare to IDEXX Laboratories?

Henry Schein (NASDAQ:HSIC) and IDEXX Laboratories (NASDAQ:IDXX) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership.

IDEXX Laboratories has a net margin of 25.03% compared to Henry Schein's net margin of 2.96%. IDEXX Laboratories' return on equity of 71.96% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
IDEXX Laboratories	25.03%	71.96%	33.60%

Henry Schein currently has a consensus target price of $92.93, indicating a potential upside of 9.29%. IDEXX Laboratories has a consensus target price of $747.00, indicating a potential upside of 43.57%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53
IDEXX Laboratories	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55

In the previous week, Henry Schein had 1 more articles in the media than IDEXX Laboratories. MarketBeat recorded 8 mentions for Henry Schein and 7 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.55 beat Henry Schein's score of 0.64 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

IDEXX Laboratories has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.43	24.79
IDEXX Laboratories	$4.30B	9.52	$1.06B	$14.22	36.59

Henry Schein has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market.

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

IDEXX Laboratories beats Henry Schein on 11 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Merit Medical Systems?

Henry Schein (NASDAQ:HSIC) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Merit Medical Systems has a net margin of 9.22% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Merit Medical Systems	9.22%	13.75%	8.10%

Henry Schein has higher revenue and earnings than Merit Medical Systems. Henry Schein is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.43	24.79
Merit Medical Systems	$1.52B	3.47	$128.49M	$2.42	36.42

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Henry Schein had 4 more articles in the media than Merit Medical Systems. MarketBeat recorded 8 mentions for Henry Schein and 4 mentions for Merit Medical Systems. Henry Schein's average media sentiment score of 0.64 beat Merit Medical Systems' score of 0.63 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Henry Schein currently has a consensus target price of $92.93, suggesting a potential upside of 9.29%. Merit Medical Systems has a consensus target price of $100.00, suggesting a potential upside of 13.46%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Henry Schein beats Merit Medical Systems on 10 of the 17 factors compared between the two stocks.

How does Henry Schein compare to Insulet?

Henry Schein (NASDAQ:HSIC) and Insulet (NASDAQ:PODD) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, Henry Schein and Henry Schein both had 8 articles in the media. Insulet's average media sentiment score of 0.70 beat Henry Schein's score of 0.64 indicating that Insulet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Insulet	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein currently has a consensus price target of $92.93, suggesting a potential upside of 9.29%. Insulet has a consensus price target of $186.68, suggesting a potential upside of 35.15%. Given Insulet's higher possible upside, analysts plainly believe Insulet is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53
Insulet	1 Sell rating(s)	12 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.46

Henry Schein has higher revenue and earnings than Insulet. Henry Schein is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.43	24.79
Insulet	$2.71B	3.54	$247.10M	$5.35	25.82

96.6% of Henry Schein shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 0.4% of Insulet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Henry Schein has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, Insulet has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market.

Insulet has a net margin of 12.29% compared to Henry Schein's net margin of 2.96%. Insulet's return on equity of 29.29% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Insulet	12.29%	29.29%	13.31%

Summary

Insulet beats Henry Schein on 10 of the 15 factors compared between the two stocks.

How does Henry Schein compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

In the previous week, Henry Schein had 4 more articles in the media than AMN Healthcare Services. MarketBeat recorded 8 mentions for Henry Schein and 4 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 0.64 beat AMN Healthcare Services' score of 0.46 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AMN Healthcare Services presently has a consensus price target of $36.50, suggesting a potential downside of 0.24%. Henry Schein has a consensus price target of $92.93, suggesting a potential upside of 9.29%. Given Henry Schein's stronger consensus rating and higher possible upside, analysts clearly believe Henry Schein is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

Henry Schein has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.65
Henry Schein	$13.18B	0.72	$398M	$3.43	24.79

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market.

AMN Healthcare Services has a net margin of 3.06% compared to Henry Schein's net margin of 2.96%. AMN Healthcare Services' return on equity of 19.92% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Henry Schein	2.96%	15.97%	5.56%

Summary

Henry Schein beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

Get Henry Schein News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSIC vs. The Competition

Export

Metric	Henry Schein	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$9.39B	$10.02B	$7.27B	$13.21B
Dividend Yield	N/A	2.61%	2.52%	22.89%
P/E Ratio	24.79	28.61	196.87	19.42
Price / Sales	0.72	4.79	562.72	81.54
Price / Cash	10.82	116.31	77.16	53.04
Price / Book	2.57	5.14	10.71	6.03
Net Income	$398M	$315.68M	$3.50B	$380.34M
7 Day Performance	1.64%	-0.61%	-2.90%	-2.32%
1 Month Performance	-4.39%	-4.03%	-7.38%	-5.29%
1 Year Performance	34.14%	10.16%	3.04%	-2.94%

Henry Schein Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSIC Henry Schein	2.8362 of 5 stars	$85.03 +0.9%	$92.93 +9.3%	+35.0%	$9.39B	$13.18B	24.79	25,000
COO Cooper Companies	4.6821 of 5 stars	$56.77 -0.2%	$71.47 +25.9%	-21.2%	$10.80B	$4.24B	19.38	15,000
IDXX IDEXX Laboratories	4.6747 of 5 stars	$527.07 +1.7%	$747.00 +41.7%	-17.8%	$40.84B	$4.30B	37.07	11,000	Positive News Analyst Forecast
MMSI Merit Medical Systems	3.5021 of 5 stars	$87.14 +2.1%	$100.00 +14.8%	+11.0%	$5.10B	$1.52B	36.01	7,500	Analyst Upgrade
PODD Insulet	4.009 of 5 stars	$135.62 +3.0%	$195.40 +44.1%	-56.1%	$9.13B	$2.71B	25.35	5,400	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSIC) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to Insulet?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MMSI, PODD, and AMN

How does Henry Schein compare to Cooper Companies?

Does the media favor HSIC or COO?

Do insiders & institutionals hold more shares of HSIC or COO?

Do analysts prefer HSIC or COO?

Which has stronger earnings and valuation, HSIC or COO?

Which has more risk & volatility, HSIC or COO?

Is HSIC or COO more profitable?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Is HSIC or IDXX more profitable?

Do analysts prefer HSIC or IDXX?

Does the media favor HSIC or IDXX?

Which has better valuation and earnings, HSIC or IDXX?

Which has more volatility & risk, HSIC or IDXX?

Do insiders and institutionals hold more shares of HSIC or IDXX?

Summary

How does Henry Schein compare to Merit Medical Systems?

Is HSIC or MMSI more profitable?

Which has higher valuation and earnings, HSIC or MMSI?

Do insiders & institutionals have more ownership in HSIC or MMSI?

Does the media favor HSIC or MMSI?

Which has more volatility and risk, HSIC or MMSI?

Do analysts prefer HSIC or MMSI?

Summary

How does Henry Schein compare to Insulet?

Does the media prefer HSIC or PODD?

Do analysts prefer HSIC or PODD?

Which has better valuation & earnings, HSIC or PODD?

Do institutionals and insiders hold more shares of HSIC or PODD?

Which has more risk & volatility, HSIC or PODD?

Is HSIC or PODD more profitable?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Does the media favor AMN or HSIC?

Do analysts prefer AMN or HSIC?

Which has stronger earnings & valuation, AMN or HSIC?

Do insiders and institutionals have more ownership in AMN or HSIC?

Which has more volatility & risk, AMN or HSIC?

Is AMN or HSIC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools